1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow vosaroxin: new trials by email Literature Review of vosaroxin trials Research Report on vosaroxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR Idarubicin, Daunorubicin, HD Cytarabine - Acute Myeloid Leukemia (AML) | Phase 2 / Phase 3 | Recruiting | University Hospital, Angers | 3100 | 2015-01-01 | 2026-07-17 |
| Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations Arm A Mylotarg plus DA Versus CPX-351, Arm B Vosaroxin and Decitabine, Arm D Small molecule or Not - Acute Myeloid Leukaemia, Myelodysplastic Syndrome | Phase 2 / Phase 3 | Unknown | Cardiff University | 1600 | 2014-10-30 | 2020-01-23 |
| Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML vosaroxin + cytarabine, placebo + cytarabine - Acute Myeloid Leukemia | Phase 3 | Completed | Sunesis Pharmaceuticals | 711 | 2010-12-17 | 2018-08-22 |
Leukemia, Myeloid, Acute (3) · Hematologic Diseases (1) · Leukemia (1) · Myelodysplastic Syndromes (1) · Neoplasms (1)
Cardiff University (1) · Sunesis Pharmaceuticals (1) · University Hospital, Angers (1)
France (2) · United Kingdom (2) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Germany (1) · Hungary (1) · Italy (1) · New Zealand (1) · Poland (1) · South Korea (1) · Spain (1)
Linda Neuman, MD (1) · Nigel Russell, Prof (1)